SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending amid discussions surrounding recent earnings and forward guidance, particularly a large AI data center contract. While some community members express excitement over the company's growth potential and a possible short squeeze, others voice concerns about revenue projections, cash flow, and potential currency exchange losses. The stock's volatility and recent price action are also key talking points.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation ($ACHR) is trending following news of its electric powertrain supply agreement with Anduril and EDGE Group, marking a new revenue stream for the eVTOL company. Community members are discussing the potential impact of this military contract, with some speculating about future partnerships and revenue, while others express concerns about share dilution and short positions.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending downwards as the community debates whether this is a temporary pullback or the start of a longer bear market, with some fearing a drop to previous support levels. Discussions include the potential impact of macroeconomic factors and large institutional players, while others speculate on possible catalysts for a reversal. Sentiment is mixed, with some traders buying the dip and others bracing for further declines.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the crypto community debates its potential amidst market fluctuations, with some pointing to increased volume and accumulation patterns as bullish signals. Others express frustration with LTC's price action, comparing it unfavorably to other cryptocurrencies like ZEC and questioning its long-term value. Community members are closely watching for a breakout and discussing potential catalysts like government actions and ETF developments.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

LKNCY is trending as investors discuss strong revenue growth, margin compression, and expansion plans. Community members are also closely watching for updates on a potential U.S. relisting, with some speculating about the timing and potential impact.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending amidst news of its acquisition of Northern Data and a $250 million commitment from Tether, with community members highlighting the potential for a short squeeze given the high short interest. Discussions revolve around Tether's increasing stake in Rumble and the potential for the platform to become a key player in AI infrastructure. Despite positive developments, some investors express frustration with the stock's performance and question management's strategy.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell is trending due to a rare double downgrade from Morgan Stanley, citing concerns about rising memory component prices and their impact on margins, even amidst optimism from J.P. Morgan regarding AI server demand. The community is debating the validity of the downgrade and its proximity to upcoming earnings, while some anticipate a bounce following Nvidia's earnings and the potential for a swing trade. Discussions also include broader market concerns, such as a potential recession and the concentration of value in a few tech giants.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

MCRB is trending amid ongoing speculation about a potential acquisition by Nestle, with community chatter focusing on whether a deal will materialize. Some traders are interpreting the price action and volume as suggestive of manipulation, while others point to Nestle's existing investment in Seres and the microbiome space as reasons for a buyout. Discussions also include potential partnership scenarios and the impact of recent cost-cutting measures.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending as investors discuss its potential breakout and momentum, possibly fueled by new orders and improving execution. Community members are actively debating whether recent after-hours activity is a genuine surge or a 'glitch,' while highlighting the company's wide-body cycle and potential new contracts. Broader news includes updates on Rolls-Royce's Trent engine durability and its involvement in nuclear projects, particularly the Wylfa site.

iShares Bitcoin Trust ETF - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending due to Bitcoin's recent price volatility, with community members debating potential support levels and future price movements. Discussions include the impact of institutional investment, particularly related to ETF flows, and whether Bitcoin can maintain its value. Some traders are taking advantage of the dip by loading up on options, while others express concern about potential further downside.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nuvalent Announces Public Offering of Common Stock

Nuvalent Announces Public Offering of Common Stock Nuvalent Announces Public Offering of Common Stock PR Newswire CAMBRIDGE, Mass., Nov. 17, 2025 CAMBRIDGE, Mass., Nov. 17, 2025 /PRNewswire...

Nuvalent Shares Jump 14% After Positive Pivotal ALKOVE-1 Trial Results In ALK-Positive NSCLC

(RTTNews) - Nuvalent, Inc. (NUVL) surged 14.24% to $110.24, up $13.74, following an announcement of strong topline data from its pivotal ALKOVE-1 trial evaluating neladalkib (NVL-655) in...

Nuvalent Reports 31% Response Rate In Patients With Advanced Form Of Lung Cancer

Nuvalent reports durable neladalkib responses in pretreated and TKI-na ve ALK-positive NSCLC, with strong rates in the ALKOVE-1 trial.read more...

<ul class="summary-bullets"><li>In 253 TKI-pre-treated patients, the review found an objective response rate (ORR) of 31%.</li><li>In a subgroup of 63 lorlatinib-naïve patients, the ORR rose to 46%.</li><li>Stifel raised its price target on the stock to $135 from $115 and reiterated a ‘Buy’ rating.</li></ul><p>Nuvalent, Inc. (NUVL) shares were in the spotlight on Monday after the company announced strong topline results from its ALKOVE-1 Phase 1/2 trial, evaluating its investigational drug Neladalkib in patients with advanced ALK-positive non-small cell lung cancer (NSCLC)&nbsp;</p><p>The patients in the trial have previously received tyrosine kinase inhibitors (TKIs).</p><h2 class="st-heading-2">Clinical Data Highlights</h2><p>In 253 TKI-pre-treated patients, the review found an objective response rate (ORR) of 31%, with estimated durations of response of 64% and 53% at 12-month and 18-month marks, respectively.&nbsp;</p><p>In a subgroup of 63 lorlatinib-naïve patients, the ORR rose to 46%, with estimated 12- and 18-month response durability of 80% and 60%, respectively.</p><p>Neladalkib demonstrated activity in tumors within the brain (intracranial responses), targeting key drivers of disease progression. The safety profile also appeared manageable, with only 5% of patients stopping treatment and 17% reducing the dose.</p><h2 class="st-heading-2">What Is The Next Step?&nbsp;</h2><p>Nuvalent plans to review these results with the U.S. Food and Drug Administration at a pre-New Drug Application (NDA) meeting. Following the trial results,&nbsp;<a href="https://stocktwits.com/symbol/NUVL/news">Nuvalent’s stock&nbsp;</a>traded over 15% higher on Monday afternoon.&nbsp;</p><p>On Stocktwits, retail sentiment around the stock jumped to ‘bullish’ from ‘neutral’ territory the previous day. Message volume improved to ‘high’ from ‘normal’ levels in 24 hours.&nbsp;</p><figure class="image"><img style="aspect-ratio:931/109;" src="https://news.stocktwits-cdn.com/Screenshot_2025_11_17_122945_png_015c7480d2.webp" alt="NUVL’s Sentiment Meter and Message Volume as of 12:10 p.m. ET on Nov. 17, 2025 | Source: Stocktwits" width="931" height="109"><figcaption>NUVL’s Sentiment Meter and Message Volume as of 12:10 p.m. ET on Nov. 17, 2025 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Wall Street’s Response&nbsp;</h2><p>Leerink analyst Stephen Gengaro boosted his target on the stock to $149 from $140, maintaining an ‘Outperform’ rating after reviewing the topline results, according to TheFly.&nbsp;</p><p>He stated that the data validate Neladalkib’s design, particularly its ability to target both single and compound ALK resistance mutations, signaling longer-lasting responses in ALK-positive non–small cell lung cancer (NSCLC).</p><p>Stifel raised its price target to $135 from $115 and reiterated a ‘Buy’ rating, citing ‘highly encouraging’ data.&nbsp;</p><p>NUVL stock has gained over 42% in 2025 and over 27% in the last 12 months.&nbsp;</p><p>Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-datavault-stock-rising-today/cLPk6IbREe9">Why Is Datavault Stock Rising Today?</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the Nuvalent logo is seen displayed on a smartphone screen. 

Why Did Nuvalent Stock Surge 15% Today?

In 253 TKI-pre-treated patients, the review found an objective response rate (ORR) of 31%.

Equity

The company announced strong topline results from its ALKOVE-1 Phase 1/2 trial, evaluating its investigational drug Neladalkib.


Nuvalent Announces Positive Topline Pivotal Data from ALKOVE-1 Clinical Trial of Neladalkib for TKI Pre-treated Patients with Advanced ALK-positive NSCLC

Nuvalent Announces Positive Topline Pivotal Data from ALKOVE-1 Clinical Trial of Neladalkib for TKI Pre-treated Patients with Advanced ALK-positive NSCLC Nuvalent Announces Positive Topline Pivotal...

Candriam S.C.A. Sells 52,870 Shares of Nuvalent, Inc. $NUVL

Candriam S.C.A. lessened its holdings in shares of Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 14.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange...

Nuvalent Announces Timing of Topline Pivotal Data for TKI Pre-treated Patients with Advanced ALK-positive NSCLC from ALKOVE-1 Clinical Trial of Neladalkib

Nuvalent Announces Timing of Topline Pivotal Data for TKI Pre-treated Patients with Advanced ALK-positive NSCLC from ALKOVE-1 Clinical Trial of Neladalkib Nuvalent Announces Timing of Topline Pivotal...

Nuvalent (NASDAQ:NUVL) Now Covered by Canaccord Genuity Group

Canaccord Genuity Group started coverage on Nuvalent in a report on Wednesday. They set a "buy" rating and a $126.00 price target for the company...

Nuvalent (NASDAQ:NUVL) Releases Earnings Results, Misses Expectations By $0.32 EPS

Nuvalent (NASDAQ:NUVL - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($1.70) earnings per share for the quarter, missing the consensus estimate of ($1.38) by...

Nuvalent, Inc. (NASDAQ:NUVL) Receives Average Recommendation of "Moderate Buy" from Analysts

Nuvalent, Inc. (NASDAQ:NUVL - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the fourteen ratings firms that are covering the company, MarketBeat Ratings reports. One...

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.

Nuvalent Inc - Ordinary Shares - Class A

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$1.48	--	--	N/A
Q3 '25	-$1.61	-$1.70	-5.72%	MISSED
Q2 '25	-$1.22	-$1.39	-13.49%	MISSED
Q1 '25	-$1.10	-$1.18	-7.61%	MISSED
Q4 '24	-$1.08	-$1.05	3.18%	BEAT

NUVL
Nuvalent Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest NUVL News

NUVLNuvalent Inc - Ordinary Shares - Class A